ArrowMark Colorado Holdings LLC Sells 27,942 Shares of Merit Medical Systems, Inc. $MMSI

ArrowMark Colorado Holdings LLC cut its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 4.3% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 622,116 shares of the medical instruments supplier’s stock after selling 27,942 shares during the period. ArrowMark Colorado Holdings LLC owned about 1.05% of Merit Medical Systems worth $51,779,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. Wellington Management Group LLP grew its position in Merit Medical Systems by 377.7% during the 3rd quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock worth $103,248,000 after acquiring an additional 980,823 shares during the last quarter. Norges Bank acquired a new position in Merit Medical Systems in the 2nd quarter worth about $53,697,000. Thrivent Financial for Lutherans raised its position in Merit Medical Systems by 250.5% in the third quarter. Thrivent Financial for Lutherans now owns 750,066 shares of the medical instruments supplier’s stock valued at $62,428,000 after purchasing an additional 536,072 shares during the last quarter. Greenhouse Funds LLLP boosted its stake in shares of Merit Medical Systems by 48.3% during the third quarter. Greenhouse Funds LLLP now owns 871,927 shares of the medical instruments supplier’s stock valued at $72,570,000 after purchasing an additional 284,015 shares in the last quarter. Finally, Bessemer Group Inc. boosted its stake in shares of Merit Medical Systems by 160,206.3% during the third quarter. Bessemer Group Inc. now owns 203,589 shares of the medical instruments supplier’s stock valued at $16,946,000 after purchasing an additional 203,462 shares in the last quarter. 99.66% of the stock is currently owned by institutional investors.

Merit Medical Systems Stock Up 2.6%

Shares of Merit Medical Systems stock opened at $69.95 on Friday. The stock’s 50-day moving average is $80.41 and its 200 day moving average is $83.80. Merit Medical Systems, Inc. has a one year low of $67.42 and a one year high of $107.27. The firm has a market cap of $4.16 billion, a price-to-earnings ratio of 33.00, a PEG ratio of 2.03 and a beta of 0.62. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.34 and a quick ratio of 2.95.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.96 by $0.08. The business had revenue of $393.94 million during the quarter, compared to the consensus estimate of $390.77 million. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.The firm’s revenue for the quarter was up 10.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.93 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Equities research analysts anticipate that Merit Medical Systems, Inc. will post 3.37 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on MMSI. Barrington Research boosted their target price on shares of Merit Medical Systems from $106.00 to $109.00 and gave the stock an “outperform” rating in a report on Wednesday, February 25th. Needham & Company LLC dropped their price target on shares of Merit Medical Systems from $108.00 to $101.00 and set a “buy” rating for the company in a research note on Wednesday, February 25th. BTIG Research started coverage on shares of Merit Medical Systems in a report on Friday, February 6th. They set a “buy” rating and a $107.00 price target on the stock. Zacks Research cut shares of Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 18th. Finally, Canaccord Genuity Group increased their price objective on Merit Medical Systems from $93.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, December 17th. Eight analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $103.33.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.